Drugs Xagena

Xagena Mappa
Xagena Newsletter

Search results for "Savaysa"

Edoxaban ( Lixiana, Savaysa ) is an oral factor Xa ( FXa ) inhibitor in clinical development for stroke prevention in patients with atrial fibrillation, an elderly population that frequently receives ...

The FDA ( Food and Drug Administration ) has approved the anti-clotting drug Savaysa ( Edoxaban tablets ) to reduce the risk of stroke and systemic embolism in patients with atrial fibrillation that i ...

Warfarin ( Coumadin ) is the most widely used oral anticoagulant worldwide, but serious bleeding complications are common. Researchers have tested whether genetic variants can identify patients who ...